A recent report published by Infinium Global Research on oncology
nutrition market provides an in-depth analysis of segments and sub-segments in the
global as well as regional oncology nutrition market. The study also highlights
the impact of drivers, restraints, and macro indicators on the global and
regional oncology nutrition market over the short term as well as long term.
The report is a comprehensive presentation of trends, forecast and dollar
values of the global oncology nutrition market. According to the report, the global
oncology nutrition market is projected to grow at a CAGR of 8.3% over the
forecast period of 2019-2025.
The increasing prevalence’s of cancer across the globe, the surge
in demand for nutritional food from the homecare segment with a rise in focus
towards nutrition are key factors drives the growth of the global oncology
nutrition market. As per the World Health Organization, the global cancer
burden is estimated to have risen to 18.1 million new cases and 9.6 million
deaths in 2018. Oncology nutrition helps in healing wounds after chemotherapy,
hormone therapy, radiation therapy, surgery, immunotherapy, and other
treatment. Additionally, the growing prevalence of malnutrition in patients
affected by cancer and the significance of nutritional intervention is another
factor is likely to contribute the market growth. However, the high cost of
oncology nutrition products may hamper the market growth. Furthermore, product
innovation, particularly with respect to non-GMO based formulas, creates
significant opportunities for the growth of the oncology nutrition market. For
instance, Nestlé Health Science and Virtual Health Partners Collaborate to
launch innovative COPES™ (Cancer Oriented Personalized Eating & Emotional
Support) program, provide nutrition and wellness support for patients with cancer.
Geographically, the global oncology nutrition market is bifurcated
into North America, Europe, Asia- Pacific and Row. North America dominates the
global oncology nutrition market over the forecast period. As per the National
Cancer Institutes, in 2018, around 17 million new cases of cancer were
recorded. The growing prevalence’s of cancer and growth in the aging population
who are highly prone to chronic and acute ailments in this region are trigger
regional growth of the market. Asia- Pacific oncology nutrition market is
anticipated to expand at a rapid CAGR during the forecast period. The growth of
this region is attributed owing to the growing awareness regarding the benefits
of nutritional food for cancer patients, the growing elderly population, and
growing healthcare expenditure.
The report on global oncology nutrition market covers segments
such as cancer type. On the basis of cancer type, the sub-markets include head
& neck, stomach & gastrointestinal, liver, pancreatic, lung, and
breast.
The report provides profiles of the companies in the market such
as B. Braun Melsungen AG, Fresenius Kabi, Danone S.A., Nestlé S.A., and Abbott
Laboratories.
The report provides deep insights into the demand forecasts,
market trends, and micro and macro indicators. In addition, this report
provides insights into the factors that are driving and restraining the growth
in this market. Moreover, The IGR-Growth Matrix analysis given in the report
brings an insight into the investment areas that existing or new market players
can consider. The report provides insights into the market using analytical
tools such as Porter's five forces analysis and DRO analysis of oncology
nutrition market. Moreover, the study highlights current market trends and
provides forecast from 2019-2025. We also have highlighted future trends in the
market that will affect the demand during the forecast period. Moreover, the
competitive analysis given in each regional market brings an insight into the
market share of the leading players.
Please Choose One of them.